| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.41▲ | 3.41▲ | 3.38▲ | 3.40▲ | 3.30▲ |
| MA10 | 3.40▲ | 3.38▲ | 3.36▲ | 3.44▼ | 2.59▲ |
| MA20 | 3.41▲ | 3.37▲ | 3.38▲ | 3.30▲ | 1.88▲ |
| MA50 | 3.37▲ | 3.38▲ | 3.41▲ | 2.43▲ | 1.56▲ |
| MA100 | 3.36▲ | 3.42▼ | 3.44▼ | 1.80▲ | 2.66▲ |
| MA200 | 3.38▲ | 3.45▼ | 2.95▲ | 1.50▲ | 2.78▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.010▲ | 0.009▲ | -0.061▼ | 0.249▲ |
| RSI | 59.775▲ | 55.140▲ | 52.860▲ | 60.715▲ | 72.838▲ |
| STOCH | 45.952 | 83.854▲ | 63.603 | 35.757 | 87.239▲ |
| WILL %R | -25.000 | -6.250▲ | -11.765▲ | -59.710 | -15.955▲ |
| CCI | 37.500 | 97.849 | 113.306▲ | -50.857 | 107.736▲ |
|
Tuesday, October 14, 2025 01:39 PM
Pyxis Oncology, Inc. (PYXS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ...
|
|
Thursday, October 09, 2025 12:30 AM
BOSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing antibody-drug conjugate (ADC) therapeutics for difficult-to-treat cancers, today ...
|
|
Monday, September 29, 2025 05:00 PM
BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to-treat ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/10/25 | 3.30 | 3.44 | 3.28 | 3.42 | 330,636 |
| 29/10/25 | 3.39 | 3.49 | 3.28 | 3.31 | 387,796 |
| 28/10/25 | 3.38 | 3.49 | 3.26 | 3.40 | 438,473 |
| 27/10/25 | 3.46 | 3.55 | 3.17 | 3.39 | 870,718 |
| 24/10/25 | 3.43 | 3.55 | 3.395 | 3.46 | 315,778 |
| 23/10/25 | 3.43 | 3.55 | 3.33 | 3.38 | 401,391 |
| 22/10/25 | 3.53 | 3.57 | 3.2312 | 3.49 | 955,082 |
| 21/10/25 | 3.57 | 3.75 | 3.45 | 3.58 | 430,595 |
| 20/10/25 | 3.40 | 3.75 | 3.40 | 3.58 | 798,890 |
| 17/10/25 | 3.45 | 3.45 | 3.26 | 3.36 | 569,711 |
|
|
||||
|
|
||||
|
|